关于药物的禁忌与许可声明——放宽规则 - Suppr

Suppr

超能文献

Forbidden and Permitted Statements about Medications--Loosening the Rules.

作者信息

Avorn Jerry, Sarpatwari Ameet, Kesselheim Aaron S

出版信息

N Engl J Med. 2015 Sep 3;373(10):967-73. doi: 10.1056/NEJMhle1506365.

DOI:10.1056/NEJMhle1506365

PMID:26332553

Abstract

摘要

相似文献

Forbidden and Permitted Statements about Medications--Loosening the Rules.

N Engl J Med. 2015 Sep 3;373(10):967-73. doi: 10.1056/NEJMhle1506365.

Clinical trial transparency--antidote to weaker off-label-promotion rules?

N Engl J Med. 2014 Jul 3;371(1):1-3. doi: 10.1056/NEJMp1402969.

Off-label marketing and the First Amendment.

N Engl J Med. 2013 Jan 10;368(2):103-5. doi: 10.1056/NEJMp1214926. Epub 2012 Dec 12.

Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.

Shattuck lecture. Innovation, regulation, and the FDA.

N Engl J Med. 2010 Dec 2;363(23):2228-32. doi: 10.1056/NEJMsa1007467.

Pharmaceutical promotion to physicians and First Amendment rights.

N Engl J Med. 2008 Apr 17;358(16):1727-32. doi: 10.1056/NEJMsb0708920.

Higher First Amendment hurdles for public health regulation.

N Engl J Med. 2011 Aug 18;365(7):e13. doi: 10.1056/NEJMp1107614. Epub 2011 Aug 3.

The First Amendment and FDA restrictions on off-label uses: the call for a new approach.

Food Drug Law J. 2008;63(2):391-406.

Snake oil salesmen or purveyors of knowledge: off-label promotions and the commercial speech doctrine.

Cornell J Law Public Policy. 2013 Winter;23(2):337-93.

Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.

Food Drug Law J. 2006;61(2):385-418.

引用本文的文献

The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.

PLoS Med. 2018 May 8;15(5):e1002564. doi: 10.1371/journal.pmed.1002564. eCollection 2018 May.

Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Int J Health Policy Manag. 2016 Feb 3;5(4):271-4. doi: 10.15171/ijhpm.2016.11.

An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

PLoS Med. 2016 Mar 15;13(3):e1001978. doi: 10.1371/journal.pmed.1001978. eCollection 2016 Mar.

Unhealthy marketing of pharmaceutical products: An international public health concern.

J Public Health Policy. 2016 May;37(2):149-59. doi: 10.1057/jphp.2016.6. Epub 2016 Feb 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验